Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Divestments (2017 - 2020)

Historic Divestments for Aptevo Therapeutics (APVO) over the last 3 years, with Q1 2020 value amounting to $28.1 million.

  • Aptevo Therapeutics' Divestments changed N/A to $28.1 million in Q1 2020 from the same period last year, while for Dec 2020 it was $28.1 million, marking a year-over-year increase of 1518260.87%. This contributed to the annual value of $28.1 million for FY2020, which is 56164.71% up from last year.
  • Per Aptevo Therapeutics' latest filing, its Divestments stood at $28.1 million for Q1 2020.
  • Aptevo Therapeutics' Divestments' 5-year high stood at $28.1 million during Q1 2020, with a 5-year trough of -$714000.0 in Q4 2017.
  • Over the past 3 years, Aptevo Therapeutics' median Divestments value was $65000.0 (recorded in 2018), while the average stood at $5.5 million.